ResearcherOslo University HospitalActive in the last 2 years

A. Lopez

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9039-7042; OpenAlex author ID A5068172551. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data. Co-author DOI 10.1186/s13040-026-00546-0 ↗
Biomarker discovery and patient stratification in pancreatic cancer using incomplete multi-omics data. Last author DOI 10.1371/journal.pcbi.1014735 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tero A. Aittokallio · 2 shared papers, 2026 · strength 0.79
- Paper Biomarker discovery and patient stratification in pancreatic cancer using incomplete multi-omics data. DOI 10.1371/journal.pcbi.1014735 ↗
- Paper Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data. DOI 10.1186/s13040-026-00546-0 ↗
Alejandra Paja-García · 1 shared paper, 2026 · strength 0.43
- Paper Biomarker discovery and patient stratification in pancreatic cancer using incomplete multi-omics data. DOI 10.1371/journal.pcbi.1014735 ↗
John Zobolas · 1 shared paper, 2026 · strength 0.36
- Paper Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data. DOI 10.1186/s13040-026-00546-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.